Free Trial
ASX:OSP

Osprey Medical (OSP) Stock Price, News & Analysis

Osprey Medical logo

About Osprey Medical Stock (ASX:OSP)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.25 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

Receive OSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osprey Medical and its competitors with MarketBeat's FREE daily newsletter.

OSP Stock News Headlines

I was wrong. Dead wrong.
One small investment into these three companies at IPO and you’ve outperformed almost any other investment you could make. Unfortunately, you can’t go back in time and invest in what became the three most dominant companies in the tech world.
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints
See More Headlines

OSP Stock Analysis - Frequently Asked Questions

Osprey Medical, Inc. (ASX:OSP) announced its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.04) EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Osprey Medical investors own include Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO), DW8 (DW8) and Dacian Gold (DCN).

Company Calendar

Last Earnings
8/14/2019
Today
11/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.96 million
Book Value
A$0.20 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:OSP) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners